Table 1.
Subjects | Gender | Scr (mg/dL) | Scys (mg/L) | Equation (mL/min/1.73 m2) |
---|---|---|---|---|
CKD-EPIscr (eGFRscr) | female | ≤0.7 | 141 × (Scr/0.7)-0.329 × 0.993age × 1.018 | |
>0.7 | 141 × (Scr/0.7)-1.209 × 0.993age × 1.018 | |||
male | ≤0.9 | 141 × (Scr/0.9)-0.411 × 0.993age | ||
>0.9 | 141 × (Scr/0.9)-1.209 × 0.993age | |||
CKD-EPIcys (eGFRcys) | female | ≤0.8 | 133 × (Scys/0.8)-0.499 × 0.996age × 0.932 | |
>0.8 | 133 × (Scys/0.8)-1.328 × 0.996age × 0.932 | |||
male | ≤0.8 | 133 × (Scys/0.8)-0.499 × 0.996age | ||
>0.8 | 133 × (Scys/0.8)-1.328 × 0.996age | |||
CKD-EPIscr_cys (eGFRscr_cys) | female | ≤0.7 | ≤0.8 | 130 × (Scr/0.7)-0.248 × (Scys/0.8)- 0.375 × 0.995age |
>0.8 | 130 × (Scr/0.7)-0.248 × (Scys/0.8)- 0.711 × 0.995age | |||
>0.7 | ≤0.8 | 130 × (Scr/0.7)-0.601 × (Scys/0.8)- 0.375 × 0.995age | ||
>0.8 | 130 × (Scr/0.7)-0.601 × (Scys/0.8)- 0.711 × 0.995age | |||
male | ≤0.9 | ≤0.8 | 135 × (Scr/0.9)-0.207 × (Scys/0.8)- 0.375 × 0.995age | |
>0.8 | 135 × (Scr/0.9)-0.207 × (Scys/0.8)- 0.711 × 0.995age | |||
>0.9 | ≤0.8 | 135 × (Scr/0.9)-0.601 × (Scys/0.8)- 0.375 × 0.995age | ||
>0.8 | 135 × (Scr/0.9)-0.601 × (Scys/0.8)- 0.711 × 0.995age | |||
abbreviated _MDRD (eGFRa_MDRD) | 186 × (Scr)-1.154 × (age)-0.203 × (×0.742 if female) | |||
Chinese _MDRD (eGFRc_MDRD) | 175 × (Scr)-1.234 × (age)-0.179 × (×0.79 if female) | |||
original MDRD (eGFR_MDRD) | 186 × (Scr)-1.154 × (age)-0.203 × (×0.742 if female) × (×1.233 if Chinese) |
Scr serum creatinine, Scys serum cystatin C